Viking Global Investors
KITE

Viking Global Investors’s Kite Pharma, Inc. KITE Stock Holding History

Viking Global Investors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-480,155
Closed -$49.8M – 73
2017
Q2 		$49.8M Buy
+480,155
New +$39.2M 0.34% 45
2016
Q4 		– Sell
-516,815
Closed -$28.9M – 84
2016
Q3 		$28.9M Sell
516,815
-2,008,682
-80% -$112M 0.12% 55
2016
Q2 		$126M Buy
2,525,497
+265,669
+12% +$13.1M 0.54% 41
2016
Q1 		$104M Buy
2,259,828
+52,625
+2% +$2.55M 0.46% 38
2015
Q4 		$136M Sell
2,207,203
-265,377
-11% -$18.7M 0.51% 38
2015
Q3 		$138M Buy
2,472,580
+1,795,246
+265% +$113M 0.53% 45
2015
Q2 		$41.3M Buy
+677,334
New +$38.6M 0.16% 51
2014
Q4 		– Sell
-200,000
Closed -$5.7M – 85
2014
Q3 		$5.7M Buy
+200,000
New +$4.95M 0.02% 59

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Viking Global Investors's KITE Position: Q3 2017 in Review

Viking Global Investors sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 480,155 shares — an estimated $49.8M sold.

Viking Global Investors first reported a position in KITE in Q3 2014 and held it in 8 quarters. The position peaked at $138M in Q3 2015. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Viking Global Investors reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Viking Global Investors sold 480,155 Kite Pharma, Inc. shares in Q3 2017, an estimated $49.8M.
  • Viking Global Investors first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 8 quarters.
  • Viking Global Investors's Kite Pharma, Inc. position peaked at $138M in Q3 2015.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Viking Global Investors's 13F filing for Q3 2017, filed 14 Nov 2017.